Abstract Cockle shell-derived calcium carbonate nanoparticles have shown promising potentials as slow drug-releasing compounds in cancer chemotherapy. In this study, we evaluated the in vitro efficacy of docetaxel (DTX)-loaded CaCO 3 NP on 4T1 cell line. This was achieved by evaluating the following: cytotoxicity using MTT assay, fluorescence imaging, apoptosis with Annexin V assay, cell cycle analysis, scanning (SEM) and transmission electron microscopy (TEM), and scratch assay. Based on the results, DTXCaCO 3 NP with a DTX concentration of 0.5 μg/mL and above had comparable cytotoxic effects with free DTX at 24 h, while all concentrations had similar cytotoxic effect on 4T1 cells at 48 and 72 h. Fluorescence and apoptosis assay showed a higher (p < 0.05) number of apoptotic cells in both free DTX and DTX-CaCO 3 NP groups. Cell cycle analysis showed cycle arrest at subG0 and G2/M phases in both treatment groups. SEM showed presence of cellular blebbing, while TEM showed nuclear fragmentation, apoptosis, and vacuolation in the treatment groups. Scratch assay showed lower (p < 0.05) closure in both free DTX and DTX-CaCO 3 NP groups. The results from this study showed that DTXCaCO 3 NP has similar anticancer effects on 4T1 cells as free DTX, and since it has a slow release rate, it is a more preferred substitute for free DTX.
Introduction
Breast cancer is one of the most devastating cancers affecting women worldwide. Therapeutic drugs such as taxanes have been used to limit its metastasis but with adverse toxic side effects which can only be reduced by reducing the dosage administered or shortening the schedule of administration (Engels et al. 2005 ). However, this will limit its therapeutic efficacy in cancer tissues. Over the past few decades, research has been focused on developing different types of nanoparticles aimed at delaying the release of anticancer therapeutic drugs such as taxanes. These include liposomal carriers, solid lipid particles, biodegradable nanoparticles, polyelectrolyte nanoparticles, and non-spherical nanoparticles like nanotubes (Natarajan et al. 2014) . Calcium carbonate nanoparticles have gained popularity as a slow drug release compound because they are 100% biodegradable with a slow degradable matrix that allows for delayed release of drugs in tumor tissues (Maleki Dizaj et al. 2015) . Calcium carbonate microparticles have also been reported to increase the pH in the cancer tissue resulting in growth stasis (Som et al. 2016) .
Calcium carbonate nanoparticles derived from cockle shell have been shown to possess good slow release properties for both antibiotics and anticancer agents such as doxorubicin and docetaxel (Islam et al. 2011; Islam et al. 2012; Islam et al. 2013; Kamba et al. 2013b, a) . However, its slow release property was dependent on the pH of the solution. Physiologic solutions with pH 7.4 showed slower release of drug bounded to the nanoparticle than pH 5.8 (Kamba et al. 2013b, a; Shafiu Kamba et al. 2013 ). In our recent study, the release of docetaxel (DTX) from calcium carbonate nanoparticles was less than 80% after 48 and 72 h but showed a comparable cytotoxicity to MCF-7 cells as free docetaxel within the same time period (Hammadi et al. 2017) .
In vitro breast cancer cell lines such as MCF-7 and 4T1 cells have provided tremendous insights into breast cancer pathogenesis and chemotherapy in both in vitro and in vivo models. 4T1 cell lines, which were derived from mice breast cancer, have been used in cancer studies for decades (Redelman and Hunter 2007; de Souza Garcia et al. 2014; Li et al. 2014; McRae Page et al. 2014; Mohamad et al. 2015) . Docetaxel has been shown to induce cell cycle arrest in cancer cells. This arrest in cellular mitosis was related to apoptosis observed in the treated cancer cells (Hernández-Vargas et al. 2007a, b; Sánchez-Moreno et al. 2012) . However, this effect has not been demonstrated in 4T1 cells exposed to DTXCaCO 3 NP and it is not known if the concentration of DTX released by the CaCO 3 NP is sufficient to induce cell cycle arrest as free DTX would. Thus, this study was designed to evaluate the antitumor effects of DTX-CaCO 3 NP against 4T1 breast cancer cell line based on its ability to induce cell cycle arrest, apoptosis, and cytotoxicity. The data obtained will provide valuable insights into the use of CaCO 3 NP as a slow drug release compound for DTX delivery with a view of reducing its toxic effects without altering its efficacy.
Materials and Methods
Cell propagation The cell lines 4T1 mice breast cancer and MCF-10A were obtained from the ATCC collection (ATCC, Manassas, VA, USA). 4T1 cell was maintained in RPMI supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin. MCF-10A cell was maintained in DMEM-F12 media supplemented with hydrocortisone (0.5 μg/ml), insulin (10 μg/ml), hEGF (20 ng/ml), and 10% (v/v) FBS. All cells were kept in a 37°C incubator equipped with 5% CO2 (Hammadi et al. 2017 ).
In vitro cytotoxicity evaluation (mitochondrial activity) The 4T1 breast cancer cells were seeded into a 96-well plate at a density of 1 × 10 4 cells/well and incubated for 24 h. During each experiment, the medium was removed and the 4T1 cells were cultured again with 100 μL of different concentrations of DTX-CaCO 3 NP, and docetaxel in culture medium suspension (2 to 0.0625 μg/mL) or of the control (culture medium only). After 24, 48, and 72 h incubation at 37°C and 5% CO 2 , the media was aspirated and the cells were rinsed two times with pH 7.4 PBS before being replaced with another 100 μL media prior to MTT treatment. Then, 20 μL of 3-[4, 5-dimethylthiazol-2-yl]-3, 5-diphenyl tetrazolium bromide dye (MTT reagent) was added to each well, and the plates were incubated for 4 h at 37°C. Then, the dye was removed and 100 μL of sterile dimethylsulfoxide (DMSO) was added to each well, and shaken in the dark for 30 min to solubilize the crystals and release the color product into the solution, and the optical densities were measured at 570 nm in a micro-titer plate reader (Kamba et al. 2013b, a) . Triplicates were carried out for each cell line. The following formula was used to determine the percentage of viable cells.
Percentage of cell viability
¼ OD Sample at 570 nm .
OD control at 570 nm
CaCO 3 nanoparticle biocompatibility assay The MCF10A cells line was seeded into a 96-well plate at density of 1 × 10 4 cells/well and incubated for 24 h. During each experiment, the medium was removed and the cells were cultured again with 100 μL of different concentrations of free CaCO 3 NP (1000-31.25 μg), 72 h incubation at 37°C and 5% CO 2 , the media was aspirated and the cells were rinsed two times with pH 7.4 PBS before being replaced with another 100 μL media prior to MTT treatment. MTT assay was carried out as previously described (Hammadi et al. 2017) .
AO/PI double staining AO/PI double staining was assayed to determine the morphological changes in 4T1 upon treatment with Docetaxel. The cells were seeded in 6 well plates at a concentration of 1 × 10 6 cells/well and incubated overnight. The next day, the cells were treated with IC 50 of DTX for 24, 48, and 72 h. Afterwards, the cells were trypsinized and washed with PBS twice. The harvested cells were suspended in 100 μl PBS and stained with 10 μg/ml of each dye. Acridine Orange is a stain that is permeable to viable cells and can stain the cell's DNA directly (Haughland 2002) . This dye emits a green fluorescence once it is excited. Propidium iodide, on the other hand, is a dye that is impermeable to viable cells. It can bind to DNA only when the cells are dead; it emits a red-orange fluorescence instead. The mixture was viewed under a fluorescent microscope (Nikon, Japan) (Abu et al. 2014) . Viable, early apoptotic, and late apoptotic cells were estimated in six microscopic fields and presented in percentage.
Transmission electron microscopy and scanning electron microscopy features of DTX-CaCO 3 NP on 4T1 cells The 4T1 breast cancer cells were co-cultured with media alone (control), free DTX or DTX-CaCO 3 NP and incubated for 72 h at 37°C. The cells were detached by trypsinization and pelleted by centrifuged at 1350×g for 10 min. The pellets were fixed, blocked, washed, dehydrated, embedded in resin, sectioned, and stained for transmission electron microscopy (TEM) as described previously (Kamba et al. 2014 ). The stained samples were then viewed under a transmission electron microscope (Phillips, Eindhoven, The Netherlands). Similarly, samples for SEM were prepared from 4T1 breast cancer cells co-cultured with either media alone (control), free DTX or DTX-CaCO 3 NP and incubated for 72 h at 37°C. The cells were detached by trypsinization, pelleted, fixed, washed, dehydrated, dried, and gold coated using SEM coating unit (E5100 Polaron, UK) before it was viewed using the SEM (JOEL 64000, Japan) as described previously (Kamba et al. 2014) .
Cell cycle analysis The cells were seeded in 6-well plates at a density of 1 × 10 6 cells/well. The following day, the cells were treated with DTX and IC 50 concentrations of 1, 0.5, and 0.125 μg/mL for 24, 48, and 72 h, respectively. The cells were then trypsinized, washed with PBS and centrifuged at 250×g for 10 min. The cell cycle assay was done using BD cell cycle reagent (CycleTest™ Plus DNA reagent kit, Becton Dickinson, Belgium) according to manufacturer's protocol.
Annexin V/FITC assay The Annexin Vassay was carried out using the Annexin V Kit (BD Pharmingen, San Diego, CA, USA). The cells were seeded in 6-well plates at a concentration of 1 × 10 6 cells/well overnight. The seeded cells were treated with DTX IC 50 concentrations of 1, 0.5, and 0.125 μg/mL for 24, 48, and 72 h, respectively. After the designated incubation time, the treated cells were collected and harvested according to the desired time points. They were subsequently stained with 5 μl of FITC Annexin V and 5 μl of PI. The mixture was left to incubate at room temperature for 15 min. Afterwards, the cells were analyzed using the FACS system (Becton Dickinson, USA) (Abu et al. 2014) .
Scratch assay This assay was done using the protocol outlined by (Liang et al. 2007 ). 4T1 cells were seeded to full confluency in 6-well plates overnight. The following day, a scratch was introduced in the middle of the well using a sterile yellow tip. The media was discarded and replaced with fresh media containing IC 50 concentrations of docetaxel. The rate of migration towards the center of the wound was captured every 4 h up until 48 h (Nikon, Japan). The following formula was used to calculate the rate of migration: (Pang et al. 2011) .
The following formula was used to calculate the rate of migration:
Percentage of wound closure
¼
Area of wound at 0h-wound area at n ð Þ h ð Þ wound area at 0h x100
Microscopic examination of cell morphology The 4T1 (1 × 10 4 cells/well) were seeded into 6-well plates. Following incubation for 24 h RPMI complete media either with 2 μg/ml docetaxel and DTX-CaCO 3 NP and 1, and 0.5 μg/ml for 24, 48, 72 h. The untreated cells were used as a negative control. General morphological and membrane changes were examined under an inverted microscope (CMM 214; Nikon Corporation, Tokyo, Japan) (Radwan et al. 2016 ).
Statistical analysis
The data are presented as statistical means ± S.E. The cut-off p value for significance was set at p < 0.05. The statistical comparison analysis was done using the oneway ANOVA with Tukey post hoc test. Graphpad Prism version 7 was used to perform all statistical analysis.
Results
Cell viability The in vitro cell viability at 24 h was above 50% at all concentrations. However, the DTX-CaCO 3 NP group had a higher (p < 0.05) viability compared to free DTX at concentrations ranging from 0.0625-0.5 μg/mL. After 48 h, cell viability was slightly above 50% at the highest dose of 2 μg/mL, but unlike earlier at 24 h, there was no difference (p > 0.05) between the DTX-CaCO 3 NP and DTX groups. At 72 h, the cell viability was < 50% at all concentrations, with no difference (p > 0.05) between DTX-CaCO 3 NP and DTX groups (Fig. 1) .
A normal mammary cell line (MCF10A) was used to evaluate the cytotoxicity of calcium carbonate nanoparticle (CaCO 3 NP) alone. Based on the results obtained, the cell viability was above 90% even at the highest concentration of 1000 μg/mL. This shows that the CaCO 3 NP is safe for the normal mammary cell line and does not induce toxicity after 72 h of treatment (Fig. 2) .
Florescent imaging
The results of the fluorescence imaging showed the presence of viable cells, early apoptosis, late apoptosis and necrosis in the treatment groups (Fig. 3) . At 24 h, the DTX group had a lower number of viable cells than the DTX-CaCO 3 NP. However, apoptosis was higher in the DTX group, while necrosis was not different (p > 0.05) between the DTX and DTX-CaCO 3 NP groups. At 48 and 72 h, both DTX and DTX-CaCO 3 NP groups had comparable number of viable, apoptotic, and necrotic cells (Fig. 4) .
Annexin V assay
The results from annexin Vassay in 4T1 cells using flow cytometer showed different distribution of cell cytopathology, apoptosis, and necrosis in all the groups over a period of 72 h (Fig. 5) . At 24 h, the DTX group had a lower viability (p < 0.05) than the control and DTX-CaCO 3 NP, while early apoptosis was higher in the DTX group. At 48 and 72 h, there were no differences (p > 0.05) between the DTX and DTXCaCO 3 NP groups with regard to cellular viability, apoptosis, and necrosis, while the control group had a significantly lower (p < 0.05) value of all changes in comparison to the treated groups (Fig. 6) .
Cell cycle analysis The cell cycle assay peaks representing different stages in 4T1 cells untreated and treated with DTX and DTX-CaCO 3 NP are shown in Fig. 7 . Based on the summary of cell percentages at different phases, cells at subG0 phase were higher (p < 0.05) in the DTX and DTX-CaCO 3 NP groups at 24 h indicating arrest at this phase, while cells at the G0/G1 and S phases were decreased (p < 0.05) in both groups. The number of cells at the G2/M phase was increased (p < 0.05) in both treatment groups, indicating cycle arrest at G2/M checkpoint. At 48 h, the subG0 and G2/M phases were higher (p < 0.05) in both treatment groups indicating arrest at these two phases, while G0/G1 phase was lower (p < 0.05) in these groups. However, there was lower number of cell accumulation than at 24 h. There was no change in the population of cells at the S phase between all groups. At 72 h, cells at the subG0 phase were increased (p < 0.05) in the treatment groups, while those in the G0/G1 phase were fewer in both treatment groups. There was no change in the percentage of cells in the S and G2/M phases in all groups (Fig. 8) Scanning and transmission electron microscopy Scanning electron micrograph of the control cells showed a smooth cellular surface with several microvilli and a few cytoplasmic projections. In both treatment groups, cytoplasmic blebbing characterized by round protrusions were evident on the cell surface. These projections are apoptotic bodies that resulted from the DTX treatment (Fig. 9) .
Transmission electron micrographs of control untreated 4T1 cells showed a normal nucleus and cytoplasm with few vacuoles. Micrographs from DTX and DTX-CaCO 3 NP show cells with fragmented nucleus and condensed chromatin around the nuclear periphery. Numerous vacuoles were also observed with the cells. The DTX-and DTX-CaCO 3 NP-treated cells were seen to be undergoing different stages of apoptosis as evidenced by numerous apoptotic bodies (Fig. 10) .
Cell scratch assay The photomicrographs of cell scratch assay after 0, 4, 8, and 24 h of scratching in control (untreated 4T1 cells), DTX, and DTX-CaCO 3 NP are shown in Fig. 11 . The estimated wound closure percentage was higher in the control group at all time periods, while both DTX and DTXCaCO 3 NP groups had a closure rate of lower than 10% at all time points. There was no difference (p > 0.05) in the closure rates between the DTX and DTX-CaCO 3 NP groups (Fig. 12) .
Cell morphology The morphological changes observed in 4T1 cells treated with DTX and DTX-CaCO 3 NP was more obvious at 48 and 72 h of treatment. The main changes observed at 24 h was cell rounding, while at 48 and 72 h, there was cellular rounding, reduced cell density, and cell detachment with floating cells in the media (Fig. 13) .
Discussion
In this study, we evaluated the in vitro efficacy of DTX loaded CaCO 3 NP in 4T1 breast cancer cell line. The use of 4T1 cancer cells in development of chemotherapy against mammary gland tumors have been pursued for decades. The cell line can be easily grown in the laboratory and used in in vitro and in vivo experimental studies (Redelman and Hunter 2007) . Based on the in vitro cytotoxicity results from this study, DTX and DTX-CaCO 3 NP had comparable cytotoxicities at 48 and 72 h. This agrees with our recent study in MCF-7 cells where both free DTX and nanoparticle-bound DTX showed similar cytotoxicity at 48 and 72 h. However, based on the drug release profile, we reported that the DTXCaCO 3 NP was only able to release about 80% of the bound drug during this period but showed comparable cytotoxicity with the free DTX. It was thus concluded that the DTXCaCO 3 NP was more effective since a lower drug amount was released that resulted in comparable effects with the free DTX (Hammadi et al. 2017) . In a study by (Sánchez-Moreno et al. 2012) , the IC 50 of free DTX was reported to be higher (45 nM) than that of DTX bound to EPI nanocapsules (9 nM) in MCF-7 cells. This was attributed to the toxic effect of the nanocapsule, since in the same study, 20 nM of free DTX did not show any cytotoxic effect on MCF-7 cells. Here, we used different IC 50 concentrations of DTX at 24, 48, and 72 h. This was based on the fact that the cytotoxicity of DTX in cells was dependent on the duration of treatment rather than on the drug concentration (Hill et al. 1994 ). Thus, in order to get an accurate IC 50 for each of the incubation times, an IC 50 value based on each time was calculated. In this study, free CaCO 3 NP showed minimal cytotoxic effects on MCF10A cells at 1000 μg/mL. This reiterates the fact that CaCO 3 has a high safety margin as a nanocarrier (Maleki Dizaj et al. 2015) .
Apoptosis was initially thought to be the main mechanism through which DTX induces cell death in cancer cells. However, it is now believed to be one of the modes of action of the drug which also includes mitotic catastrophe (Morse et al. 2005) . In this study, the cytopathological changes observed in 4T1 cells after fluorescent and annexin V assays were comparable between the free DTX and DTXCaCO 3 NP groups. This is in agreement with the cytotoxicity reported earlier and suggests that the DTX-CaCO 3 NP is as effective as the free DTX even though a lower concentration was being released from the CaCO 3 NP as reported (Hammadi et al. 2017) . In a related study by (Sánchez-Moreno et al. 2012) , no apoptosis was recorded in MCF-7 cells treated with 45.2 nM of free DTX after 24 h, while a high number of apoptosis was observed with 9.1 nM concentration of DTX-EPI nanocapsule, suggesting a lower effective concentration of DTX-EPI nanocapsule than DTX alone. In a study by (Hernández-Vargas et al. 2007a, b) , apoptosis induction by DTX in MCF-7 cells was higher at a higher DTX concentration of 100 nM, while fewer number of dead and necrotic cells were observed with a concentration of 4 nM. This agrees with the findings of (Hernández-Vargas et al. 2007a, b) , which stated that cancer cells are affected differently by DTX administration, where a lower dose induces aberrant mitosis, while a higher dose induces mitotic arrest. The DTX concentrations we used in this study are considered high since apoptosis was above 30% in the DTX-treated group.
Docetaxel is a microtubule stabilizing taxane that causes the inhibition of major cellular events, such as mitotic cell division, endosomal uptake, secretion, and transport. Evaluation of cell cycle is an important component of in vitro anticancer drug studies. In this study, both free DTX and DTX-CaCO 3 NP showed cell cycle arrest at subG0 and G2/M phases at 24 and 48 h. DTX has been reported to variably induce cell cycle arrest based on the concentrations used. A low dose of DTX has been shown to induce cell cycle arrest at other phases, while a high dose has been shown to induce mitotic arrest at G2/M phase (Hernández-Vargas et al. 2007a, b) . In this study, mitotic arrest in 4T1 cells was induced by DTX concentrations of 1 and 0.5 μg/mL at 24 and 48 h. Previously, (Hernández-Vargas et al. 2007a, b) had reported the dose-dependent effect of DTX in inducing different outcomes in cell lines. The study reported the apoptosis induced by high concentration of DTX (100 nM) to be due to mitotic arrest associated with p53, which in turn results in mitotic slippage. In an earlier study, 40 nM of free DTX and 9.1 nM of DTX-bound EPI nanocapsule were both shown to induce mitotic arrest at G2/M and S phases in MCF-7 cell line. However, there was a reduction in the accumulation of cells at G0/G1 phases in both treatment groups (Sánchez-Moreno et al. 2012) . Similarly, in a study by (Morse et al. 2005) , treatment of MCF-7 and MDAmb-231 cells with 10 nmol/L of DTX induced cell cycle arrest at G2/M and G0/G1 phases with increased arrest at 8 and 24 h, and a decrease at 48 h. Since mitotic catastrophe due to cell cycle arrest is one of the mechanisms of cell death following DTX administration, the use of a slow release DTX-CaCO 3 NP in this study did not seem to affect the efficacy of DTX in 4T1 cells. This suggests that the DTX-CaCO 3 NP has better therapeutic effect than free DTX due to its slow release which might ultimately result in lower drug toxicity in vivo.
Transmission electron microscopy is considered as the gold standard for diagnosis of apoptosis in cells. In this study, TEM evaluation showed fragmented nucleus with condensed chromatin, vacuoles, and apoptotic bodies. Apoptosis has been reported as one of the mechanisms of cell death associated with anticancer therapy. Previously, apoptosis was reported in MCF-7 cells treated with doxorubicin and Flavokawain A (Abu et al. 2014; Kamba et al. 2014) . Our results are in agreement with the findings of (Morse et al. 2005) , who reported the presence of vacuoles, both apoptotic and non-apoptotic cells and condensed mitochondria in MCF10A, MCF-7, and MDA-mb-231 cells exposed to DTX. Cytoplasmic blebbing reported in 4T1 cells treated with DTX is a characteristic feature of cellular apoptosis in cells. In a study by Wahab et al. (2009) , Zerumbone was reported to induce apoptosis typified by cytoplasmic blebbing in HeLa cells. This finding together with the TEM observations made confirms the apoptosis observed in the 4T1 cells.
Cell migration assays are used to evaluate cell proliferation following treatment with drugs. In this study, the cell scratch migration assay showed a low percentage closure in both DTX and DTX-CaCO 3 NP-treated cells. This can be attributed to the apoptosis and mitotic cell arrest observed in the treated cells. Besides, the cell morphology also showed cell rounding, low density, and detachment which impaired cell migration. Cellular dispersion and detachment have been reported in cancer cells following treatment with anticancer drugs. In our previous study, treatment of MCF-7 cells with Doxorubicin showed similar changes in cellular morphology including cell rounding and detachment (Kamba et al. 2014 ). In another Currently, the applications of CaCO3 in drug and protein delivery have been elucidated. CaCO3 Nanoparticles have shown promising delivery potentials for antibiotics such as ciprofloxacin, proteins and antitumor drugs (Ferrari et al. 2017; Hammadi et al. 2017; Maleki Dizaj et al. 2017; Peng et al. 2017 ). This success is attributed to its excellent encapsulation efficiency which results in slow release of the bound substance/compound. Tumor tissues have been reported to have an acidic pH; in vivo, this pH is counteracted by CaCO3 nanoparticle treatment to pH 7.4, which results in tumor stasis (Som et al. 2016) . Other studies have shown various successes achieved by developing hybrid CaCO3 microparticles in therapy (Neira-Carrillo et al. 2016 ). Overall, all the studies showed the remarkable drug delivery properties of CaCO3 particles for therapeutic applications.
Conclusion
This study evaluated the therapeutic efficacy of DTXCaCO 3 NP on 4T1 breast cancer cells. The results showed that binding of DTX to CaCO 3 NP did not affect the known mechanism of DTX action which involved cytotoxicity, apoptosis, and cell cycle mitotic arrest. Furthermore, morphology and cell migration assay also supported the effect of DTXCaCO 3 NP against 4T1 breast cancer. 
